Effects of cilostazol in the heart

Cilostazol is a selective phosphodiesterase 3 (PDE3) inhibitor approved by the Food and Drug Administration for treatment of intermittent claudication. It has also been used in bradyarrhythmic patients to increase heart rates. Recently, cilostazol has been shown to prevent ventricular fibrillation i...

全面介紹

Saved in:
書目詳細資料
Main Authors: Kanlop N., Chattipakorn S., Chattipakorn N.
格式: Review
語言:English
出版: 2014
在線閱讀:http://www.scopus.com/inward/record.url?eid=2-s2.0-79953647359&partnerID=40&md5=e9020097d70205ab2a2fd77cfd3bb904
http://cmuir.cmu.ac.th/handle/6653943832/1131
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!